NCT04549415View on ClinicalTrials.gov

The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

November 1, 2018

Study Completion Date

November 15, 2019

Conditions
Chronic Heart FailureCoronary Artery DiseasePreDiabetes
Interventions
DRUG

Metformin Hydrochloride

"patients were divided into 2 groups: 1st group was on lifestyle modification (LSM), 2nd group on regimen LSM+ metformin (1000 g b.i.d) during 12 months"

OTHER

lifestyle modification

Lifestyle modification Standard Principles

Trial Locations (1)

720001

National Centre of Cardiology and Internal Medicine named after academician M.Mirrakhimov, Bishkek

All Listed Sponsors
lead

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

OTHER_GOV

NCT04549415 - The Influence of Metformin on Chronic Heart Failure Clinical Course in Patients With Prediabetes | Biotech Hunter | Biotech Hunter